News
RIGL
--
0.00%
--
Penny Stocks To Buy With Analysts Targeting 76%-209% Upside
Feb 24, 2021 (Penny Stocks via COMTEX) -- Analysts Are Bullish On These 4 Penny Stocks We've discussed penny stocks and analyst ratings many times before....
Penny Stocks · 1d ago
3 Penny Stocks Outpacing The Market This Week, Time To Buy?
Feb 24, 2021 (Penny Stocks via COMTEX) -- These Penny Stocks Are Climbing Faster Than The S&P This Week When it comes to finding the best penny stocks,...
Penny Stocks · 1d ago
Top Penny Stocks To Watch Heading Into February 2021
Feb 24, 2021 (Penny Stocks via COMTEX) -- Could These Penny Stocks Bounce Next Month? With February fast approaching, investors are working out strategies to...
Penny Stocks · 1d ago
Thrombopoietin Receptor Agonist Market CAGR Status, Market Size, Share, Price, Trend And Forecast 2027 |Ameco Research
pune, India, Wed, 24 Feb 2021 06:19:29 / Comserve Inc. / -- Thrombopoietin receptor agonists have been established as the most significant in the treatment...
Comserve · 2d ago
Acquired Orphan Blood Diseases Therapeutics Market | 2021 Industry Analysis By Size, Growth, Share, Trends, Opportunities, Key Players, Business Insights, Competitive Landscape, Regional And Global Forecast To 2028
The Express Wire · 2d ago
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business Update
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its fourth quarter and year end 2020 financial results after market close on Tuesday, March 2, 2021. Rigel senior management will follow the announcement with a live conference c...
PR Newswire · 3d ago
Interleukin 1 Receptor Associated Kinase 4 Market Analysis, Size, Share, Trends and Forecast 2020-2027
pune, India, Tue, 23 Feb 2021 01:54:03 / Comserve Inc. / -- Interleukin 1 Receptor Associated Kinase 4 market is segmented by Type, and by Application....
Comserve · 3d ago
Tyrosine Protein Kinase SYK Market By Application Analysis, Regional Outlook, Competitive Strategies And Forecast 2020 - 2027 By Ameco Research
Comserve · 4d ago
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19)
Benzinga · 02/19 12:25
Global AXL Kinase inhibitor Pipeline Insights 2021: Emerging Drugs Include Sitravatinib (Mirati Therapeutics) and Bemcentinib (BerGenBio / Rigel Pharmaceuticals) - ResearchAndMarkets.com
The "AXL Kinase inhibitor - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering.
BusinessWire · 02/19 10:50
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
Zacks.com · 02/18 17:32
DJ Rigel Pharmaceuticals Price Target Raised to $11.00/Share From $8.00 by HC Wainwright & Co.
Dow Jones · 02/18 17:18
DJ Rigel Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 02/18 17:18
H.C. Wainwright Believes Rigel (RIGL) Won’t Stop Here
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Rigel (RIGL) today and set a price target of $11.00. The company's shares closed last
SmarterAnalyst · 02/18 16:20
Rigel Partners With Eli Lilly On Therapy For Autoimmune Disorders; Stock Pops 15%
Shares of Rigel Pharmaceuticals jumped more than 15% as the biotech company announced an exclusive $960 million collaboration with Eli Lilly to develop and commercialize receptor interacting serine/threonine protein kinase 1 (RIPK1) inhibitors for the trea...
SmarterAnalyst · 02/18 15:27
DJ Rigel Pharmaceuticals Shares Rise on Eli Lilly Licensing Deal >RIGL
Dow Jones · 02/18 15:21
8-K: RIGEL PHARMACEUTICALS INC
(EDGAR Online via COMTEX) -- 0001034842 false 0001034842 2021-02-18 2021-02-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 02/18 15:15
Thinking about buying stock in Avinger, Rigel Pharmaceuticals, Vistagen Therapeutics, Bio-Path, or Corvus Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AVGR, RIGL, VTGN, BPTH, and CRVS.
PR Newswire - PRF · 02/18 13:30
TWLO, RIGL, ONTX and MACK among premarket gainers
Greenland Technologies Holding Corporation (GTEC) +186% on signing co-operation agreement with SOCMA.Immunome (IMNM) +152% on discovery of antibodies neutralizing SARS-CoV-2 variants.Avinger (AVGR) +57%.Heritage Global (HGBL) +42%.U.S. Well Services (USWS)...
Seekingalpha · 02/18 13:26
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 17)
Benzinga · 02/18 13:14
Webull provides a variety of real-time RIGL stock news. You can receive the latest news about Rigel Pharms through multiple platforms. This information may help you make smarter investment decisions.
About RIGL
Rigel Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in discovering, developing and providing novel small molecule drugs that improve the lives of patients with immune and hematological disorders, cancer and rare diseases. The Company’s research focuses on signaling pathways that are critical to disease mechanisms. The Company’s product include TAVALISSE is an oral spleen tyrosine kinase (SYK) inhibitor for the treatment of adult patients with chronic immune thrombocytopenia (ITP). Its current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase I study for its interleukin receptor associated kinase (IRAK) program. In addition, it has product candidates in development with partners BerGenBio AS, Daiichi Sankyo and Aclaris Therapeutics.